Activities of six different quinolones against clinical respiratory isolates of Streptococcus pneumoniae with reduced susceptibility to ciprofloxacin in Spain

Antimicrob Agents Chemother. 2002 Aug;46(8):2665-7. doi: 10.1128/AAC.46.8.2665-2667.2002.

Abstract

Six quinolones were tested on 817 consecutive pneumococcal isolates for which ciprofloxacin MICs were high (> or =2 microg/ml); the isolates had been collected during two recent Spanish surveillance studies. For strains for which the ciprofloxacin MIC was >or =4 microg/ml, the MICs at which 90% of the isolates tested against gemifloxacin, moxifloxacin, gatifloxacin, sparfloxacin, levofloxacin, and ofloxacin were inhibited were 0.25, 1, 1, 1, 4 and 16 microg/ml, respectively, and the corresponding prevalences of resistance were 0, 1, 4.5, 9.5, 8.4 and 23%. The proportion of isolates for which the ciprofloxacin MIC is high has increased over time.

MeSH terms

  • Anti-Infective Agents / pharmacology*
  • Ciprofloxacin / pharmacology*
  • Data Collection
  • Drug Resistance, Microbial
  • Humans
  • Pneumococcal Infections / epidemiology
  • Pneumococcal Infections / microbiology*
  • Respiratory Tract Infections / epidemiology
  • Respiratory Tract Infections / microbiology*
  • Spain / epidemiology
  • Streptococcus pneumoniae / drug effects*

Substances

  • Anti-Infective Agents
  • Ciprofloxacin